Logo wahanariau.com
  2. Jerman

Jerman

Index
Globenewswire

UPDATE -- Black Forest Labs Announces Series B Investment to Accelerate Frontier Visual Intelligence

Senin, 01 Desember 2025 - 22:32:58 Wib
Globenewswire

Black Forest Labs Announces Series B Investment to Accelerate Frontier Visual Intelligence

Senin, 01 Desember 2025 - 22:18:01 Wib
Globenewswire

New Study Reveals $11.28M Annual Opportunity for Industrial Companies to Boost Competitiveness by Modernizing Closed Automation Systems

Rabu, 26 November 2025 - 22:46:59 Wib
Globenewswire

GetYourGuide Unveils 2026 Hidden Trends List: Birdwatching, Coffee Culture and Skill-Seeking Set to Drive Experience-Led Trips

Senin, 24 November 2025 - 22:55:51 Wib
Globenewswire

From Wind Tunnels to Space: Vacuum for Aerospace Research

Rabu, 19 November 2025 - 03:39:33 Wib
Globenewswire

Heidelberg Engineering Joins the Collaborative Community on Ophthalmic Innovation (CCOI) Through EssilorLuxottica’s Vision Architect Membership

Jumat, 14 November 2025 - 22:31:06 Wib
Globenewswire

CNH Brands win 2026 Farm Machine of the Year Awards

Rabu, 12 November 2025 - 22:18:35 Wib
Globenewswire

New Holland wins ‘Best Specialized’ at Tractor of the Year 2026 Awards

Selasa, 11 November 2025 - 02:54:14 Wib
Globenewswire

LEAG and Fluence to Build the Largest Battery Storage Project in Europe with a Capacity of 4 GWh

Jumat, 07 November 2025 - 23:22:02 Wib
Globenewswire

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

Rabu, 05 November 2025 - 03:00:28 Wib
Globenewswire

Boehringer Ingelheim Acquires License from Kyowa Kirin Aimed at Developing a Novel Treatment for Patients with Autoimmune Diseases

Kamis, 30 Oktober 2025 - 22:02:26 Wib
Globenewswire

ESPAS and Steinehelden Use Descartes’ Solution to Optimize Ecommerce Productivity by 500% While Supporting Special Needs of Workers

Rabu, 29 Oktober 2025 - 01:12:21 Wib
Globenewswire

RIB Software Partners with Microsoft to Accelerate AI in Construction

Selasa, 28 Oktober 2025 - 02:45:10 Wib
Globenewswire

JASCAYD® (nerandomilast) Approved in China for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Jumat, 24 Oktober 2025 - 01:15:45 Wib
Globenewswire

Boehringer’s Zongertinib Demonstrated a 77% Objective Response Rate in Treatment-naïve Patients with Advanced HER2 (ERBB2)-mutant NSCLC

Sabtu, 18 Oktober 2025 - 04:31:45 Wib
Globenewswire

Boehringer Ingelheim Advances Cancer Antibody-drug Conjugate Portfolio with Asset from AimedBio

Rabu, 15 Oktober 2025 - 21:23:58 Wib
Globenewswire

From Diversity to Impact: The Power of Diversity Funding Facility Identifies Priority Opportunity Crops for Investment

Selasa, 14 Oktober 2025 - 20:43:17 Wib
Globenewswire

U.S. FDA Approves Boehringer’s JASCAYD® (nerandomilast tablets) as First New Treatment Option for Adults with IPF in Over a Decade

Jumat, 10 Oktober 2025 - 03:05:59 Wib
Globenewswire

Rentschler Biopharma Further Expands its Services in Japan and South Korea and will Attend BioProcess International Asia

Selasa, 07 Oktober 2025 - 00:01:42 Wib
Globenewswire

Automotive: BYD Marks Impressive Presence at IAA Mobility 2025 in Munich

Kamis, 11 September 2025 - 04:54:46 Wib
Globenewswire

BYD’s Stella Li Highlights New Models, European Factory and Innovation at IAA Mobility 2025

Rabu, 10 September 2025 - 02:40:23 Wib
Globenewswire

21X Rings the Bell as Trading Starts on the World’s First Blockchain-based Exchange for Tokenized Securities and Stablecoins

Senin, 08 September 2025 - 23:16:01 Wib
Globenewswire

Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season

Selasa, 19 Agustus 2025 - 20:28:52 Wib
Globenewswire

Boehringer Ingelheim and Palatin Technologies to Develop Potential First-in-class Melanocortin Receptor Targeted Treatment for Patients with Retinal Diseases

Selasa, 19 Agustus 2025 - 20:07:57 Wib
Globenewswire

Boehringer and Click Therapeutics’ Investigational Prescription Digital Therapeutic CT-155 Meets Primary Endpoint in CONVOKE Study for Negative Symptoms in Schizophrenia

Jumat, 08 Agustus 2025 - 01:13:46 Wib